πŸ‡ΊπŸ‡Έ FDA
Patent

US 7482024

Compositions comprising an active agent

granted A61KA61K47/183A61K47/20

Quick answer

US patent 7482024 (Compositions comprising an active agent) held by Nektar Therapeutics expires Mon Jan 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Jan 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K47/183, A61K47/20, A61K9/0075, A61K9/008